Organovo shares soaring 20% pre-market after it disclosed that it has entered into an agreement with Janssen Research and Development, unit of Johnson and Johnson (JNJ) to evaluate the use of 3D bio-printed tissue in a drug discovery setting
Organovo shares soaring 20% pre-market after it disclosed that it has entered into an agreement with Janssen Research and Development, unit of Johnson and Johnson (JNJ) to evaluate the use of 3D bio-printed tissue in a drug discovery setting